Latest Breaking News On - Pharm contacts - Page 2 : comparemela.com

KemPharm Announces Appointment of Christopher Posner as New Independent Director

KemPharm Announces Appointment of Christopher Posner as New Independent Director
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Christopher posnerRichardw pascoeCompany early access programCorium incBristol myers squibb companyPfizer incKempharm incCompany board of directorsVillanova universityDrug administrationFuqua school of business at duke universityWyeth pharmaceuticals incExchange commissionEndo internationalPharma incCara therapeutics

KemPharm Announces Positive Topline Data from Phase 1 Clinical Trial Evaluating Cardiovascular Safety of Serdexmethylphenidate (SDX)

KemPharm Announces Positive Topline Data from Phase 1 Clinical Trial Evaluating Cardiovascular Safety of Serdexmethylphenidate (SDX)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Travis mickleCompany early access programCorium incDrug administrationExchange commissionKempharm incWall streetChief executive officerEarly access programConcerning forward looking statementsPrivate securities litigation reform actAnnual reportQuarterly reportPharm contactsStrategic advisorsInc jason

KemPharm to Present at the H C Wainwright 24th Annual Global Investment Conference

KemPharm to Present at the H C Wainwright 24th Annual Global Investment Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesTravisc mickleJason rando daniel kontoh boatengTiberend strategic advisors incCompany early access programCorium incDrug administrationKempharm incWall streetAnnual global investment conferenceInvestor relationsEarly access programPharm contactsStrategic advisors

KemPharm Appoints Nichol Ochsner as Vice President, Investor Relations and Corporate Communications

KemPharm Appoints Nichol Ochsner as Vice President, Investor Relations and Corporate Communications - read this article along with other careers information, tips and advice on BioSpace

United statesTravis mickleStatera biopharmaNichol ochsnerJason rando daniel kontoh boatengBristol meyers squibbVirginia universityCorium incKos pharmaceuticalsCorporate communications at medarexEnzon pharmaceuticalsKempharm incCorporate communications at auxilumDrug administrationCorporate communications at therapeuticsCorporate communications

KemPharm Announces Strategic Acquisition of Arimoclomol from Orphazyme, Expanding its Rare CNS Diseases Pipeline

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesTravis mickleJason rando daniel kontoh boatengMarc pattersonRichard pascoeCanaccord genuityCorium incDrug administrationExchange commissionEuropean unionKempharm incCommittee for medicinal products human useNew drug applicationFirst quarterEarly access programsExecutive chairman